Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Medtronic
McKinsey
AstraZeneca
McKesson

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ortataxel

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Ortataxel?

Ortataxel is an investigational drug.

There have been 4 clinical trials for Ortataxel. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2001.

The most common disease conditions in clinical trials are Kidney Neoplasms, Carcinoma, Renal Cell, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are Theradex, Mario Negri Institute for Pharmacological Research, and Roswell Park Cancer Institute.

Recent Clinical Trials for Ortataxel
TitleSponsorPhase
An Efficacy Study Of Ortataxel In Recurrent GlioblastomaMario Negri Institute for Pharmacological ResearchPhase 2
BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2
BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerRoswell Park Cancer InstitutePhase 2

See all Ortataxel clinical trials

Clinical Trial Summary for Ortataxel

Top disease conditions for Ortataxel
Top clinical trial sponsors for Ortataxel

See all Ortataxel clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Moodys
McKesson
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.